Screener
ClearPoint Neuro CLPT Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Cost of revenue | 4,372 | 3,353 |
| Gross profit | 7,756 | 5,132 |
| Research and development costs | 4,522 | 3,379 |
| Sales and marketing expenses | 6,715 | 3,834 |
| General and administrative expenses | 4,997 | 4,082 |
| Operating loss | (8,478) | (6,163) |
| Other income (expense): | ||
| Other (expense) income, net | (35) | 4 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's sales & marketing?
- ClearPoint Neuro (CLPT) reported sales & marketing of $6.72M in Q1 2026.
- How has ClearPoint Neuro's sales & marketing changed year-over-year?
- ClearPoint Neuro's sales & marketing increased by 75.1% year-over-year, from $3.83M to $6.72M.
- What is the long-term trend for ClearPoint Neuro's sales & marketing?
- Over 4 years (2021 to 2025), ClearPoint Neuro's sales & marketing has grown at a 23.3% compound annual growth rate (CAGR), from $7.13M to $16.46M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about ClearPoint Neuro's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude